TNF and Parkinson disease: None of the serum immune mediators showed any significant difference with respect to increase in H-Y stage except for TNF which intially showed an increase in patients with mild PD (H-Y scale < 2) and later showed an approximate downward trend although not significant (P > 0.05) as shown in Table 2.